MSCT血管重建和双重化疗栓塞治疗25例转移性肝癌

时间:2024-10-29 22:41:28 药学毕业论文

MSCT血管重建和双重化疗栓塞治疗25例转移性肝癌

作者:陈雄,彭永海,欧阳学农,李天然

【关键词】 肝肿瘤

MSCT vascular reconstruction and double chemoembolization through portal vein and liver artery in 25 patients with liver cancer metastases

  【Abstract】 AIM: To study the effect of MSCT vascular reconstruction and chemoembolization through portal vein and liver artery in patients with liver cancer metastases. METHODS: Twentyfive patients (male 18, female 7) with liver cancer metastases were randomized into 2 groups. In all these patients, the hepatic vessels were restructured with MSCT while 11 patients in control group received only transcatheter arterial chemoembolization (TACE) therapy and 14 patients received TACE 1 week after portal vein chemoembolization in the treatment group. TACE was steered by digital Xray and percutaneous iodized oil portal vein injection was steered by colorultrasonic imaging. 研究MSCT血管重建和双重化疗栓塞治疗转移性肝癌的效果. 方法: 选择转移性肝癌患者25(男18,女7)例,随机分为2组,采用16层螺旋CT对肝动脉、门静脉进行血管重建;11例DSA下单独给予肝动脉化疗栓塞(TACE)治疗(对照组),14例彩超引导下给予门静脉穿刺化疗栓塞(PVE)(治疗组),1 wk后于DSA下肝动脉化疗栓塞治疗,观察和比较两组治疗前后患者瘤体体积、白细胞和肝功能、生活质量变化. 结果: MSCT肝动脉、门静脉血管重建成功率均为100%,可清楚显示ⅣⅤ级肝脏血管,发现门静脉包绕肿瘤,周边以双重血供为主,随着肿块的增大,中间坏死灶无明显血供,肝动脉DSA造影提示60%转移瘤以肝动脉血供为主,结合彩超引导下介入栓塞治疗,40%门静脉除包绕肿瘤组织外,还有细小分支插入肿瘤内部,以门静脉血供为主;两组治疗前后瘤体体积、白细胞和肝功能变化、生活质量无显著差异(P

【MSCT血管重建和双重化疗栓塞治疗25例转移性肝癌】相关文章:

浅析急性肢体动脉栓塞的外科治疗03-18

川芎茶调散加减治疗血管性头痛临床观察03-04

内皮素受体拮抗剂对脑血管痉挛的治疗作用03-06

肺栓塞的紧急诊断03-08

微波与硝酸银治疗鼻中隔毛细血管瘤的疗效观察03-17

血管生成因子在血管疾病中的应用11-19

化疗药物溢出的成因及解决措施07-03

铂类化疗药物的耐药机制03-14

预防产后肺栓塞的护理干预03-16

化疗患者健康需求的调查及护理干预03-18